Search research articles
Contact Us
Filters
Showing results (131-140 of 142) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2017
Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival
Gaëlle Müller-Greven, Cathleen R Carlin, Monica E Burgett, et al.
World Neurosurgery
|
April 7, 2022
Neighborhood-Level Socioeconomic Status Predicts Extended Length of Stay After Elective Anterior Cervical Spine Surgery
Matthew J Hagan, Rahul A Sastry, Joshua Feler, et al.
Neurosurgery
|
January 26, 2023
Time of Discharge and 30-Day Re-Presentation to an Acute Care Setting After Elective Lumbar Decompression Surgery
Rahul A Sastry, Matthew Hagan, Joshua Feler, et al.
Journal of Neurosurgery. Spine
|
August 30, 2024
Social determinants of health and outcome disparities in spine tumor surgery. Part 1: An analysis of 6.6 million nationwide admissions
Oliver Y Tang, Cameron Ayala, Joshua R Feler, et al.
Journal of Neurosurgery. Spine
|
August 30, 2024
Social determinants of health and outcome disparities in spine tumor surgery. Part 2: Neighborhood disadvantage and long-term outcomes
Oliver Y Tang, Owen P Leary, Arjun Ganga, et al.
The Bone & Joint Journal
|
November 3, 2016
International consensus on the definition and classification of fibrosis of the knee joint
N S Kalson, L A Borthwick, D A Mann, et al.
Neuro-Oncology
|
August 22, 2019
Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones
Ben Yi Tew, Christophe Legendre, Mark A Schroeder, et al.
JAMA Oncology
|
February 3, 2018
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial
Martin J B Taphoorn, Linda Dirven, Andrew A Kanner, et al.
JAMA
|
December 17, 2015
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew A Kanner, et al.
Journal of Translational Medicine
|
July 1, 2018
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M Liau, Keyoumars Ashkan, David D Tran, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 142) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2017
Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival
Gaëlle Müller-Greven, Cathleen R Carlin, Monica E Burgett, et al.
World Neurosurgery
|
April 7, 2022
Neighborhood-Level Socioeconomic Status Predicts Extended Length of Stay After Elective Anterior Cervical Spine Surgery
Matthew J Hagan, Rahul A Sastry, Joshua Feler, et al.
Neurosurgery
|
January 26, 2023
Time of Discharge and 30-Day Re-Presentation to an Acute Care Setting After Elective Lumbar Decompression Surgery
Rahul A Sastry, Matthew Hagan, Joshua Feler, et al.
Journal of Neurosurgery. Spine
|
August 30, 2024
Social determinants of health and outcome disparities in spine tumor surgery. Part 1: An analysis of 6.6 million nationwide admissions
Oliver Y Tang, Cameron Ayala, Joshua R Feler, et al.
Journal of Neurosurgery. Spine
|
August 30, 2024
Social determinants of health and outcome disparities in spine tumor surgery. Part 2: Neighborhood disadvantage and long-term outcomes
Oliver Y Tang, Owen P Leary, Arjun Ganga, et al.
The Bone & Joint Journal
|
November 3, 2016
International consensus on the definition and classification of fibrosis of the knee joint
N S Kalson, L A Borthwick, D A Mann, et al.
Neuro-Oncology
|
August 22, 2019
Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones
Ben Yi Tew, Christophe Legendre, Mark A Schroeder, et al.
JAMA Oncology
|
February 3, 2018
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial
Martin J B Taphoorn, Linda Dirven, Andrew A Kanner, et al.
JAMA
|
December 17, 2015
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew A Kanner, et al.
Journal of Translational Medicine
|
July 1, 2018
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M Liau, Keyoumars Ashkan, David D Tran, et al.
Page
of 15